Stifel resumed coverage of Alphatec (ATEC) with a Buy rating and $20 price target Alphatec stood out in the firm’s U.S. spine surgeon survey as the fastest expected share gainer, giving the firm confidence in the company’s “beat-and-raise playbook,” the analyst tells investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC: